Brokers Offer Predictions for Exact Sciences Co.'s FY2025 Earnings (NASDAQ:EXAS)

Exact Sciences Co. (NASDAQ:EXAS – Free Report) – Stock analysts at Leerink Partnrs decreased their FY2025 earnings estimates for Exact Sciences in a research report issued to clients and investors on Wednesday, August 2nd. Leerink Partnrs analyst P. Souda now anticipates that the medical research company will post earnings per share of $0.83 for the […]

Related Keywords

United States ,Craig Hallum ,James Herriott ,Sarah Condella ,Stifel Nicolaus ,Leerink Partnrs ,True Wealth Design ,Securities Exchange Commission ,Sciences Price Performance ,Desjardins Global Asset Management Inc ,Assetmark Inc ,Sciences Co ,Nasdaq ,Sciences Corporation ,Institutional Investors Weigh In On Exact Sciences ,News Ratings For Exact Sciences Daily ,Ameritas Advisory Services ,Park Place Capital Corp ,Exact Sciences ,Free Report ,Exact Science ,Get Free Report ,Place Capital Corp ,Global Asset Management ,Wealth Design ,General Counsel James Herriott ,Exchange Commission ,Recurrence Score Test ,Score Test ,Oncoextra Test ,Exact Sciences Daily ,Nasdaq Exas ,Texas ,Medical ,30063p10 ,Earnings Estimates ,